Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Z Squared Inc. (ZSQR : NSDQ)

• Company Description    Coeptis Therapeutics Holdings Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals Inc., is a biopharmaceutical company developing innovative cell therapy platforms for cancer. Coeptis Therapeutics Holdings Inc., formerly known as Bull Horn Holdings Corp., is based in WEXFORD, Pa. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $8.98 Daily Weekly Monthly 20 Day Moving Average: 179,290 shares Shares Outstanding: 51.43 (millions) Market Capitalization: $461.85 (millions) Beta: -0.09 52 Week High: $21.41 52 Week Low: $6.80 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -44.60% -47.31% 12 Week -27.17% -32.67% Year To Date -36.98% -47.35%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 550 SOUTH ANDREWS AVE. SUITE 700 - FORT LAUDERDALE,FL 33301 USA ph: 954-400-9994 fax: - zsqr@mzgroup.us https://coeptistx.com

• General Corporate Information    Officers David Mehalick - Chief Executive Officer; Chairman and President Daniel Yerace - Vice President of Operations Brian Cogley - Chief Financial Officer Christine Sheehy - Vice President of Compliance and Secretary Christopher Calise - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INTERNET SOFTWARE Sector: Computer and Technology CUSIP: 98878K108 SIC: 6199 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 51.43 Most Recent Split Date: 12.00 (0.05:1) Beta: -0.09 Market Capitalization: $461.85 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 26.27 Price/Cash Flow: - Price / Sales: 326.63 EPS Growth vs. Year Ago Period: 41.44% vs. Previous Quarter: -441.67% Sales Growth vs. Year Ago Period: 80.95% vs. Previous Quarter: -86.77% ROE 03/31/26 - -92.29 12/31/25 - -110.89 09/30/25 - -173.32 ROA 03/31/26 - -73.52 12/31/25 - -78.30 09/30/25 - -104.29 Current Ratio 03/31/26 - 3.25 12/31/25 - 4.16 09/30/25 - 2.21 Quick Ratio 03/31/26 - - 12/31/25 - 4.16 09/30/25 - 2.21 Operating Margin 03/31/26 - -810.04 12/31/25 - -803.96 09/30/25 - - Net Margin 03/31/26 - -810.04 12/31/25 - -803.96 09/30/25 - - Pre-Tax Margin 03/31/26 - -910.68 12/31/25 - -900.73 09/30/25 - -2,727.94 Book Value 03/31/26 - 0.34 12/31/25 - 2.63 09/30/25 - 2.26 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.01 12/31/25 - 0.01 09/30/25 - 0.01 Debt-to-Capital 03/31/26 - 0.85 12/31/25 - 1.05 09/30/25 - 1.36

Powered by Zacks Investment Research ©